logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Meera Mohan

university of texas md anderson cancer

21H-index
192Paper Count
1.5KCitation Count
Published Papers 50
Publication Date
logo
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
errBlood Cancer Journal
IF11.6
err2026-08-22
err0
errOAAI
errMansi R. Shah; Aishee Bag; Asis Shrestha; Yetunde Ogunsesan; Anup Trikannad; Sruthi Vellanki; Sanjay Muttineni; Hira Cheema; Syed Naqvi; Sasya Dronavalli; Samer Al Hadidi; Sharmilan Thanendrarjan; Maurizio Zangari; Frits van Rhee; Aniko Szabo; Rajshekar Chakraborty; Meera Mohan; Carolina Schinke
errShare
errSave
Immune effector cell associated hematotoxicity (ICAHT) with BCMA CAR T cell therapy in the earlier lines
errBlood Cancer Journal
IF11.6
err2026-08-22
err0
errOAAI
errMeera Mohan; Anushareddy Muddasani; Hayder Alkhalisy; Lisa Rein; Jean Esselman; Binod Dhakal; Anita D’Souza; Sabarinath Venniyil Radhakrishnan; Sharmilan Thanendrarajan; Maurizio Zangari; Frits van Rhee; Aniko Szabo; Carolina Schinke
errShare
errSave
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma
errHemaSphere
IF14.6
err2026-06-07
err0
errOAAI
errGala Vega; Daniel Morillo; Christine Riedhammer; Febe Smits; Aishee Bag; Kelly Julian; Natalia Tovar Gomis; Carmen Montes Gaisan; Maria Aranzazu Bermudez; Mansi R. Shah; Ghulam Rehman Mohyuddin; Binod Dhakal; Leo Rasche; Carolina Schinke; Anita D'Souza; Aniko Szabo; Niels W. C. J. van de Donk; Rajshekhar Chakraborty; Meera Mohan
errShare
errSave
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
errBlood Cancer Journal
IF11.6
err2026-04-14
err0
errOAAI
errDoris K. Hansen; Danai Dima; Hira Mian; Jakob Devos; Ruta Brazauskas; Temitope Oloyede; Aimaz Afrough; Nausheen Ahmed; Larry Anderson; Rahul Banerjee; Jesus G. Berdeja; Aram Bidikian; Binod Dhakal; Ajoy Dias; Yvonne Efebera; Muhammad Salman Faisal; Lohith Gowda; Hamza Hashmi; Abu-Sayeef Mirza; Meera Mohan; Ravi Narra; Ashley E. Rosko; Mark Schroeder; Taiga Nishihori; Heather Landau; Saad Usmani; Marcelo C. Pasquini; Othman S. Akhtar; Surbhi Sidana; Krina K. Patel
errShare
errSave
Reassessing the Duration of Induction Therapy for Newly Diagnosed, Transplant-Eligible Myeloma Patients in the Context of Quadruple CD38 Monoclonal Antibody-Based Regimens: Is 24 Weeks Optimal?
errAmerican Journal of Hematology
IF9.9
err2026-01-26
err0
errOAAI
errMeera Mohan; Sabarinath Radhakrishnan; Carolina Schinke; Eirini Katodritou; Rafeal Fonseca
errShare
errSave
Plasma Cell Leukemia: Genomic Features and Their Potential Relevance for Exploring Clinical Actionability
errBlood Advances
IF7.1
err2025-12-22
err0
errOAAI
errMeera Mohan; Natalie Danziger; Othman Salim Akhtar; Ravi Narra; Marcello Pasquini; Sabarinath Radhakrishnan; Binod Dhakal; Anita D’Souza; Douglas Lin; Caleb Ho; Razelle Kurzrock
errShare
errSave
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
errJNCI: Journal of the National Cancer Institute
IF0
err2025-11-09
err0
errOAAI
errMaria Mainou, MD; Muatassem Alsadhan, MD; Kalliopi Tsapa, MD; Alissa Visram, MD; Hira Mian, MD; Rakesh Popat, MD; Elias K Mai, MD; Rajshekhar Chakraborty, MD; Samer Al Hadidi, MD; Meera Mohan, MD; Aniko Szabo, PhD; Oliver Van Oekelen, MD; Edward R Scheffer Cliff, MBBS; Ghulam Rehman Mohyuddin, MD
errShare
errSave
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study
errBlood Cancer Journal
IF11.6
err2025-11-07
err0
errOAAI
errSamer Al Hadidi; Aniko Szabo; Bhavesh Mohan Lal; Aishee Bag; Simon Zhen; Yetunde Ogunsesan; Evanka Annyapu; Binod Dhakal; Divaya Bhutani; Sharmilan Thanendrarajan; Maurizio Zangari; Anita D’Souza; Suzanne Lentzsch; Frits van Rhee; Rajshekhar Chakraborty; Carolina Schinke; Meera Mohan; Mansi R. Shah
errShare
errSave
Stem cell boost for immune effector cell associated hematotoxicity in multiple myeloma: minimizing long-term complications and expanding post CAR T-cell therapy relapse options
errEXPERT REVIEW OF HEMATOLOGY
IF2.1
err2025-10-01
err1
PREAI
errMohan, Meera; Schinke, Carolina
errShare
errSave
Bispecific antibody therapy in CNS myeloma: Early evidence from a multicentre cohort
errBritish Journal of Haematology
IF3.8
err2025-08-26
err0
errOAAI
errAlexandra Noveihed; Samer Al Hadidi; Meera Mohan; Mansi R. Shah
errShare
errSave
IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels
errBlood Advances
IF7.1
err2025-07-23
err0
errOAAI
errRahul Banerjee; Meera Mohan; Kai Rejeski; Benjamin R. Puliafito; Diana D. Cirstea; Gurbakhash Kaur; Shonali Midha; Georgia J. McCaughan; Nikhil M. Kumar; Nikita Mehra; Bhausaheb Bagal; Noopur S. Raje
errShare
errSave
The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
errBlood Advances
IF7.1
err2025-07-19
err0
errOAAI
errAsis Shrestha; Sharmilan Thanendrarajan; Aishee Bag; Binod Dhakal; Maurizio Zangari; Samer Al-Hadidi; Frits van Rhee; Anita D’Souza; Nishi Shah; Mansi R. Shah; Meera Mohan; Carolina Schinke
errShare
errSave
Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis
errLeukemia
IF13.4
err2025-07-16
err0
PREAI
errKritika Yadav; Meera Mohan; Charlotte Wagner; Rajshekhar Chakraborty; Douglas Sborov; Amandeep Godara; Brian McClune; Carolina Schinke; Binod Dhakal; Anita D’Souza; Aniko Szabo; Ghulam Rehman Mohyuddin
errShare
errSave
Addressing practical challenges with bispecific antibody therapy in multiple myeloma
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2025-04-01
err0
PREAI
errVasudevan, Sreeraj; Lal, Bhavesh Mohan; Vojjala, Nikhil; Mohan, Meera
errShare
errSave
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation
errTRANSPLANTATION AND CELLULAR THERAPY
IF4.4
err2024-12-01
err0
PREAI
errAkhtar, Othman S.; Arshad, Shanze; Lian, Qinghua; Ahn, Kwang W.; D'Souza, Anita; Dhakal, Binod; Mohan, Meera; Pasquini, Marcelo; Longo, Walter; Shah, Nirav N.; Fenske, Timothy S.; Hamadani, Mehdi
errShare
errSave
Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant Center
errTRANSPLANTATION AND CELLULAR THERAPY
IF4.4
err2024-12-01
err0
PREAI
errWu, James Fan; Estrada-Merly, Noel; Dhakal, Binod; Mohan, Meera; Narra, Ravi Kishore; Pasquini, Marcelo C.; D'Souza, Anita
errShare
errSave
Prevalent Treatment Patterns of Teclistamab and Talquetamab for Multiple Myeloma (MM): Experience from 609 Patients
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errChunara, Farheen; Shah, Mansi R.; Shah, Nishi; Kent, Jessica; Mohyuddin, Ghulam Rehman; Radhakrishnan, Sabarinath, V; Kaur, Gurbakhash; Chakraborty, Rajshekhar; Rasche, Leo; Schinke, Carolina; D'Souza, Anita; Szabo, Aniko; Mohan, Meera
errShare
errSave
Chimeric Antigen Receptor T Cells (CAR-T) Vs. Bispecific Antibody (BsAb) Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): A Systematic Review and Metaanalysis
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errUandenboom, Hayley; Szabo, Aniko; Akhtar, Othman S.; Narra, Ravi; Mohan, Meera; D'Souza, Anita; Pasquini, Marcelo C.; Dhakal, Binod
errShare
errSave
The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errShrestha, Asis; Thanendrarajan, Sharmilan; Bag, Aishee; Dhakal, Binod; Zangari, Maurizio; Al Hadidi, Samer; Lentzsch, Suzanne; van Rhee, Frits; D'Souza, Anita; Chakraborty, Rajshekhar; Shah, Nishi; Shah, Mansi R.; Mohan, Meera; Schinke, Carolina
errShare
errSave
Systemic Review and Meta-Analysis of Safety and Efficacy of Bispecific Antibodies Among Older Adults with Multiple Myeloma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errNasrollahi, Elham; Gundroo, Hafsa M.; Alford, Becky; Freeman, Ciare Louise; Dhakal, Binod; Narra, Ravi; Pasquini, Marcelo C.; D'Souza, Anita; Mohan, Meera; Mhaskar, Rahul; Salim, Othman
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
B
Bart Barlogie
H-index: 138 · Papers: 1.2K
G
Gareth J. Morgan
H-index: 124 · Papers: 1.9K
R
Rafaël Fonseca
H-index: 120 · Papers: 893
J
Jeffrey S. Ross
H-index: 112 · Papers: 1.5K
N
Noopur Raje
H-index: 102 · Papers: 1.0K
View more